Novartis Contracts with Cryoport to Support Novartis Cell Therapies

July 25, 2017

Applied Clinical Trials

Novartis has signed an aggreement contracting Cryoport-provider of logistics solutions for biopharmaceutical, IVF, and animal health organizations globally-over an initial three-year tern for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.

Read the full release here.

 

 

Related Content:

News